I heard a theory on some podcast that the ulterior motive here may be to try to incentivize more R&D into Alzheimer's pharma. This approval is thus a green ligh

I heard a theory on some podcast that the ulterior motive here may be to try to incentivize more R&D into Alzheimer's pharma. This approval is thus a green light signal.